Controversy and debate on dengue vaccine series—paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs-Reference-Cited by-同舟云学术

Controversy and debate on dengue vaccine series—paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs

Published:2018-03 Issue: Volume:95 Page:137-139
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Dans Antonio L.,Dans Leonila F.,Lansang Mary Ann D.,Silvestre Maria Asuncion A.,Guyatt Gordon H.

Publisher

Elsevier BV

Subject

Epidemiology

Reference9 articles.

1. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease;Hadinegoro;N Engl J Med,2015

2. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial;Capeding;Lancet,2014

3. Efficacy of a tetravalent dengue vaccine in children in Latin America;Villar;N Engl J Med,2015

4. Immune enhancement of viral infection;Halstead;Prog Allergy,1982

5. The complexity of antibody-dependent enhancement of dengue virus infection;Guzman;Viruses,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbazole to indolazepinone scaffold morphing leads to potent cell-active dengue antivirals;European Journal of Medicinal Chemistry;2024-03

2. Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B/NS3 protease inhibitors;Archiv der Pharmazie;2023-08-15

3. Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement;Frontiers in Immunology;2023-06-02

4. Philippine immunization coverage and dengvaxia: An infodemiological study;Pediatrics International;2023-01

5. Dengue, West Nile, and Zika Viruses: Potential Novel Antiviral Biologics Drugs Currently at Discovery and Preclinical Development Stages;Pharmaceutics;2022-11-20